Evaluation and assessment of rosuvastatin 40 mg treatment in high risk dyslipidemic patients (EARTH Study)

Evaluation and assessment of rosuvastatin 40 mg treatment in high risk dyslipidemic patients (EARTH Study)

Bibliographic Details
Main Authors: R. Karnik, A. Trailokya, P. Kamlesh, Q. Mukaddam, M. Naik
Format: Article
Language:English
Published: Elsevier 2014-11-01
Series:Indian Heart Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S0019483214005264

Internet

http://www.sciencedirect.com/science/article/pii/S0019483214005264

Similar Items